From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: the world's greatest musicMagpie expert opines

By Tom Winnifrith | Wednesday 17 May 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with domestic woes and legal opinion on the claims of the IRA man. In the main body of today's podcast I look at Purplebricks (PURP) and the role of Neil Woodford and Link. I cover Microsaic (MSYS), Deepverge (DVRG), Pantheon Resources (PANR), Asimilar (ASLR), Argo Blockchain (ARB) - placing at 6p?. I also relay the thoughts of the world's greatest living expert on musicMagpie (MMAG) and why it is doomed. If you hurry and book a seat at Sharestock - where less than a third of seats are still free - you can meet the expert, who was also a great Quindellologist - on September 23. You can book HERE

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:44:52